This is a healthy volunteers trial. Thyrogen is used in patients with thyroid cancer.
Conditions
Interventions
Trade Name: Thyrogen
Product Name: Thyrogen
Product Code: tradename: thyrogen
Pharmaceutical Form: Powder for injection*
Pharmaceutical form of the placebo: Injection*
Route of administration of the p
Sponsors
Medical University of Vienna
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Men and women without evidence of thyroid disease. Age between 20-45. Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range
Exclusion criteria
Exclusion criteria: Prior or present history of thyroid disease. Pregnancy or nursing. Significant cardiac, renal, pulmonary or hepatic disease. Recent surgery or trauma. Malnutrition. Ingestion of medications known to affect the thyroid function. Alcohol or drug dependence. Previous administration of rhTSH.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main Objective: The main objective of the trial is the effect of recombinant human thyrotropin in bone metabolism and its correlation to the potential changes in the T-lymphocyte cytokine production pattern in healthy volunteers.;Secondary Objective: ;Primary end point(s): | — |
Countries
Austria
Outcome results
None listed